Major Recall of Clear Eyes Eye Drops Due to Sterility Concerns
By Editor • August 22, 2026 • 1 min read
Nearly 40,000 bottles of Clear Eyes eye drops are recalled due to sterility concerns, posing possible health risks.
Read moreBy Editor • August 22, 2026 • 1 min read
Nearly 40,000 bottles of Clear Eyes eye drops are recalled due to sterility concerns, posing possible health risks.
Read moreBy Editor • August 21, 2026 • 1 min read
Heidi Overton's FDA nomination is at risk due to her Trump ties, while estrogen patch shortages escalate amid increased demand.
Read moreBy Editor • August 20, 2026 • 1 min read
Publix's frozen berries recall has been elevated to Class I by the FDA due to E. coli concerns, posing serious health risks.
Read moreBy Editor • August 20, 2026 • 1 min read
Heidi Overton has been nominated for the FDA commissioner role after Kyle Diamantas declined the permanent position.
Read moreBy Editor • August 20, 2026 • 1 min read
The FDA has approved Ultragenyx's new gene therapy, marking a notable achievement in the biotech sector.
Read moreBy Editor • August 20, 2026 • 1 min read
Capricor Therapeutics' efforts to prevent FDA rejection of its Duchenne muscular dystrophy treatment appear futile, requiring a new clinical trial for approval.
Read moreBy Editor • August 20, 2026 • 1 min read
Despite challenges, my son prepares for his second year of graduate studies while facing uncertainty over Capricor's Duchenne muscular dystrophy treatment.
Read moreBy Editor • August 19, 2026 • 1 min read
Trump has nominated Heidi Overton, a key health policymaker, to lead the FDA, praising her as a vital contributor to his administration's health agenda.
Read moreBy Editor • August 19, 2026 • 1 min read
Heidi Overton is set to be nominated as FDA commissioner, while a new mRNA cancer vaccine shows promise in treating melanoma.
Read moreBy Editor • August 19, 2026 • 2 min read
Clinical trial participation offers hope for patients, but many face significant barriers in finding and enrolling in studies.
Read more